Impact of Clonal Hematopoiesis on the Myeloid Gene Regulatory Networks that Modulate Cancer Evolution and Response to Therapy 2020 Momentum Fellow Pablo Sánchez Vela, MD, Memorial Sloan Kettering Cancer Center Read More
Loss of the Non-Canonical BAF Complex as a Driver and Therapeutic Target in SF3B1-Mutant MDS and Leukemia 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Robert Bradley, PhD, Fred Hutchinson Cancer Research Center Read More
Targeting Leukemia Stem Cells by Disrupting Translational Fidelity 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Robert Signer, PhD, University of California San Diego Read More
Clonal Evolution of Pre-Leukemic Hematopoietic Stem Cells in Human Myeloid Malignancies 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Ravi Majeti, MD, PhD, Stanford University School of Medicine Read More
Mechanisms of Tumor-Initiation in B-Lymphoid Malignancies 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Markus Müschen, MD, PhD, Yale University Read More
In Vivo Generation of Chimeric Antigen Receptor Cells to Treat Hemopoietic Malignancies 2020 PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP Ron Levy, MD, Stanford University School of Medicine Read More
